Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases

BACKGROUND: Despite chemotherapy innovations, prognosis of patients with chemotherapy-refractory or -unfit multiple metastases (CRMM/CUMM) remains poor. In this prospective study, the efficacy and toxicity of helical tomotherapy for CRMM/CUMM were evaluated. MATERIALS AND METHODS: Between 2014 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yuki, Shibamoto, Yuta, Kishi, Kazushi, Kita, Nozomi, Kondo, Takuhito, Murai, Taro, Sugie, Chikao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989439/
https://www.ncbi.nlm.nih.gov/pubmed/35402042
http://dx.doi.org/10.5603/RPOR.a2022.0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989439/
https://www.ncbi.nlm.nih.gov/pubmed/35402042
http://dx.doi.org/10.5603/RPOR.a2022.0016

Ejemplares similares